New CEO says company will have enough investor demand to absorb the holding if sold
Value of portfolio fell 5% in first half of the year
Four main assets on track to reach ‘important milestones’
Seen and heard: Nama to sell John Player site as Marlet to build 1,000 units in Tallaght
Plus, good times return for top AIB clients
Almost 51% vote against plan at health firm’s agm over director remuneration concerns
Company says it will focus on core assets, which account for more than 70% of portfolio
Series of investments in life science companies have been badly received by the market
Seen & Heard: BAI ‘had delayed’ Xavier Niel’s takeover of Eir over concerns
Life sciences group targeting 15% growth in the total value of its investee portfolio in 2018
Artizan aims to be a leader in the microbiota-driven inflammatory diseases space
Malin’s chief investment officer received relocation payment of €393,000 last year
Irish-listed Malin to take a 31 per cent stake in US-based human therapeutics firm
Irish-based firm joins in Europe’s largest Series A life science financing
YOU MAY ALSO LIKE...
How does a post-Brexit world shape the identity and relationship of these islands
Inquests into the nightclub fire that led to the deaths of 48 people
Weddings, Births, Deaths and other family notices